中国家族性乳腺癌女性中的RAD51C种系突变 - Suppr

Suppr

超能文献

RAD51C germline mutations in Chinese women with familial breast cancer.

作者信息

Pang Zhiyuan, Yao Lu, Zhang Juan, Ouyang Tao, Li Jinfeng, Wang Tianfeng, Fan Zhaoqing, Fan Tie, Lin Benyao, Xie Yuntao

出版信息

Breast Cancer Res Treat. 2011 Oct;129(3):1019-20. doi: 10.1007/s10549-011-1574-3. Epub 2011 May 20.

DOI:10.1007/s10549-011-1574-3

PMID:21597919

Abstract

摘要

相似文献

RAD51C germline mutations in Chinese women with familial breast cancer.

Breast Cancer Res Treat. 2011 Oct;129(3):1019-20. doi: 10.1007/s10549-011-1574-3. Epub 2011 May 20.

Prevalence and characterization of BRCA1 and BRCA2 germline mutations in Chinese women with familial breast cancer.

Breast Cancer Res Treat. 2012 Apr;132(2):421-8. doi: 10.1007/s10549-011-1596-x. Epub 2011 May 26.

RAD51C germline mutations in breast and ovarian cancer patients.

Breast Cancer Res. 2010;12(4):404. doi: 10.1186/bcr2619. Epub 2010 Aug 19.

Identification and characterization of two novel germ line p53 mutations in the non-LFS/non-LFL breast cancer families in Chinese population.

Breast Cancer Res Treat. 2010 Jan;119(2):295-303. doi: 10.1007/s10549-009-0349-6. Epub 2009 Feb 24.

Germline mutations in RAD51C in Jewish high cancer risk families.

Breast Cancer Res Treat. 2012 Dec;136(3):869-74. doi: 10.1007/s10549-012-2317-9. Epub 2012 Nov 2.

Mutation status of RAD51C, PALB2 and BRIP1 in 100 Japanese familial breast cancer cases without BRCA1 and BRCA2 mutations.

Cancer Sci. 2017 Nov;108(11):2287-2294. doi: 10.1111/cas.13350. Epub 2017 Sep 18.

Comprehensive analysis of BRCA1 and BRCA2 germline mutations in a large cohort of 5931 Chinese women with breast cancer.

Breast Cancer Res Treat. 2016 Aug;158(3):455-62. doi: 10.1007/s10549-016-3902-0. Epub 2016 Jul 8.

[Single nucleotide polymorphism analysis of germline MSH6 gene mutations in Chinese hereditary non-polyposis colorectal cancer probands].

Zhonghua Zhong Liu Za Zhi. 2008 Oct;30(10):770-1.

BRCA1 germ-line mutations and tumor characteristics in eastern Chinese women with familial breast cancer.

Anat Rec (Hoboken). 2013 Feb;296(2):273-8. doi: 10.1002/ar.22628. Epub 2012 Nov 23.

Identification of a comprehensive spectrum of genetic factors for hereditary breast cancer in a Chinese population by next-generation sequencing.

PLoS One. 2015 Apr 30;10(4):e0125571. doi: 10.1371/journal.pone.0125571. eCollection 2015.

引用本文的文献

Integration of tumour sequencing and case-control data to assess pathogenicity of RAD51C missense variants in familial breast cancer.

NPJ Breast Cancer. 2022 Jan 17;8(1):10. doi: 10.1038/s41523-021-00373-y.

Familial Breast Cancer: Disease Related Gene Mutations and Screening Strategies for Chinese Population.

Front Oncol. 2021 Dec 1;11:740227. doi: 10.3389/fonc.2021.740227. eCollection 2021.

Rad51 paralogs and the risk of unselected breast cancer: A case-control study.

PLoS One. 2020 Jan 6;15(1):e0226976. doi: 10.1371/journal.pone.0226976. eCollection 2020.

A dominant RAD51C pathogenic splicing variant predisposes to breast and ovarian cancer in the Newfoundland population due to founder effect.

Mol Genet Genomic Med. 2020 Feb;8(2):e1070. doi: 10.1002/mgg3.1070. Epub 2019 Nov 28.

Comprehensive mutation detection of BRCA1/2 genes reveals large genomic rearrangements contribute to hereditary breast and ovarian cancer in Chinese women.

BMC Cancer. 2019 Jun 7;19(1):551. doi: 10.1186/s12885-019-5765-3.

Novel germline mutations and unclassified variants of BRCA1 and BRCA2 genes in Chinese women with familial breast/ovarian cancer.

BMC Cancer. 2016 Feb 6;16:64. doi: 10.1186/s12885-016-2107-6.

Single nucleotide polymorphisms in noncoding regions of Rad51C do not change the risk of unselected breast cancer but they modulate the level of oxidative stress and the DNA damage characteristics: a case-control study.

PLoS One. 2014 Oct 24;9(10):e110696. doi: 10.1371/journal.pone.0110696. eCollection 2014.

Screening of Finnish RAD51C founder mutations in prostate and colorectal cancer patients.

BMC Cancer. 2012 Nov 23;12:552. doi: 10.1186/1471-2407-12-552.

Polymorphic variations in the FANCA gene in high-risk non-BRCA1/2 breast cancer individuals from the French Canadian population.

Mol Oncol. 2013 Feb;7(1):85-100. doi: 10.1016/j.molonc.2012.08.002. Epub 2012 Sep 11.

Germline RAD51C mutations confer susceptibility to ovarian cancer.

Nat Genet. 2012 Apr 26;44(5):475-6; author reply 476. doi: 10.1038/ng.2224.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验